Product Information
TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.6505 per EA under NDC 82009016501. Its NADAC has been published 46 times since Aug 13, 2025.
Strength
5 mg/1
Manufacturer
Quallent Pharmaceuticals Health LLCNDC
82009016501
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TACROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA090509On Market Since
6/1/2025
Pharmacological Classes
Price Statistics
The NADAC for TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) has been published 46 times since Aug 13, 2025, and over the history we have for it it has declined 29.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6505 per EA |
|---|---|
| All-time high | $0.9230 (Aug 13, 2025) |
| All-time low | $0.6505 (Jun 17, 2026) |
| 52-week high | $0.9230 |
| 52-week low | $0.6505 |
| Median price | $0.7556 |
| Average price | $0.7580 |
| Largest weekly change | -6.4% (Aug 20, 2025) |
| Weeks tracked | 46 |
| Tracking since | Aug 13, 2025 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE)?
The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE), manufactured by Quallent Pharmaceuticals Health LLC, is $0.6505 per EA (NDC 82009016501), effective Jun 24, 2026.
How has the price of TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) changed over time?
Over the history we have for it, the NADAC for TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) has declined 29.5%. It has been tracked across 46 weekly CMS publications since Aug 13, 2025.
What are the highest and lowest recorded NADAC prices for TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE)?
Since Aug 13, 2025, the NADAC for TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) has ranged from a low of $0.6505 (Jun 17, 2026) to a high of $0.9230 (Aug 13, 2025), with a median of $0.7556 per EA.
Are there cheaper alternatives to TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE)?
12 NADAC-published products share the same active ingredient, strength, and dosage form as TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE), but none are currently priced below it.
Who manufactures TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE)?
TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) (NDC 82009016501) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification